Buy Syros Pharmaceuticals Stock | SYRS Stock Price & Latest News | Public.com
SYRS

Syros Pharmaceuticals

$0.00 (0.00%)Today
    View Syros Pharmaceuticals (SYRS) stock trends here

    About SYRS

    Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 20...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.21
    -0.41
    -0.62
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.44

    Actual EPS
    Q2 2021

    Stats

    Market Cap$383,39M
    Volume407,43k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.65
    1 Year Low$5.93
    Open$6.54
    High$6.69
    Low$5.93

    Buy any stock with any amount of money.

    Download the App
    Download the app